|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Rentals of medical equipment | |||||
| Sales of medical equipment and supplies | |||||
| Total revenues | |||||
| Bad debt expense | |||||
| Loss (gain) on disposals of property and equipment | |||||
| Operating income | |||||
| Interest expense on leases | |||||
| Interest expense, net | |||||
| (Gain) loss on foreign currency transactions | |||||
| Income (loss) before taxes | |||||
| Provision (benefit) for income taxes | |||||
| Net income (loss) | |||||
| Basic earnings per share | |||||
| Diluted earnings per share | |||||
| Basic | |||||
| Diluted | |||||
| Revenue | |||||
| Rentals of medical equipment | |||||
| Sales of medical equipment and supplies | |||||
| Total revenues | |||||
| Cost of inventory sold | |||||
| Operating expenses | |||||
| Right-of-use operating lease amortization and interest | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Stock-based compensation | |||||
| Acquisition-related costs | |||||
| Gain on disposals of property and equipment | |||||
| Operating income (loss) | |||||
| Interest expense | |||||
| Interest income | |||||
| Loss on extinguishment of debt | |||||
| Loss (gain) on foreign currency transactions | |||||
| Share of loss in equity method investment | |||||
| Change in fair value of derivative liability - interest rate swap | |||||
| Loss before income taxes | |||||
| Provision for income taxes | |||||
| Net loss before noncontrolling interest | |||||
| Net income attributable to noncontrolling interest | |||||
| Net loss | |||||
| Net income (loss) per share | |||||
| Basic loss per share | |||||
| Diluted loss per share | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...